Table 2 The complete list of 23 significantly enriched KEGG pathways (pvalueCutoff = 0.05 and qvalueCutoff = 0.05).
ID | Description | p-value | p.adjust | Count |
|---|---|---|---|---|
hsa04974 | Protein digestion and absorption | 4.04E-13 | 1.13E-10 | 32 |
hsa04970 | Salivary secretion | 2.51E-12 | 3.52E-10 | 31 |
hsa04020 | Calcium signaling pathway | 2.37E-06 | 0.000221 | 35 |
hsa04512 | ECM-receptor interaction | 9.82E-06 | 0.000668 | 20 |
hsa05410 | Hypertrophic cardiomyopathy (HCM) | 1.19E-05 | 0.000668 | 20 |
hsa03320 | PPAR signaling pathway | 1.89E-05 | 0.000884 | 18 |
hsa05414 | Dilated cardiomyopathy (DCM) | 4.24E-05 | 0.001697 | 20 |
hsa04260 | Cardiac muscle contraction | 6.02E-05 | 0.002106 | 18 |
hsa04510 | Focal adhesion | 0.000108 | 0.003246 | 33 |
hsa00500 | Starch and sucrose metabolism | 0.000116 | 0.003246 | 11 |
hsa04261 | Adrenergic signaling in cardiomyocytes | 0.000141 | 0.003599 | 26 |
hsa04950 | Maturity onset diabetes of the young | 0.000168 | 0.003913 | 9 |
hsa00140 | Steroid hormone biosynthesis | 0.000237 | 0.004571 | 14 |
hsa04080 | Neuroactive ligand-receptor interaction | 0.000243 | 0.004571 | 41 |
hsa00830 | Retinol metabolism | 0.000245 | 0.004571 | 15 |
hsa04971 | Gastric acid secretion | 0.000401 | 0.007012 | 16 |
hsa05202 | Transcriptional misregulation in cancer | 0.000793 | 0.013055 | 29 |
hsa04727 | GABAergic synapse | 0.000896 | 0.013615 | 17 |
hsa04972 | Pancreatic secretion | 0.000924 | 0.013615 | 18 |
hsa04371 | Apelin signaling pathway | 0.000976 | 0.013667 | 23 |
hsa04024 | cAMP signaling pathway | 0.001045 | 0.01394 | 30 |
hsa04911 | Insulin secretion | 0.001674 | 0.021304 | 16 |
hsa05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 0.002331 | 0.028382 | 14 |